Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-1.24%)
As of: Oct 22, 2026 · 12:57 PM EDT

Filana Therapeutics (FLNA) Change in Receivables (2011)

Updated

Filana Therapeutics (FLNA) reported Change in Receivables of -$640,000 for Q4 2011.

Analysis

Filana Therapeutics (FLNA) Change in Receivables (2011) Analysis & Trends

For FY2011, Filana Therapeutics posted Change in Receivables of -$7.11 million.

  • By year, Change in Receivables came in at $4.81 million in FY2010 (+128.7%) and $2.1 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn -
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn -188.00 Mn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn 1.37 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn -
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn -
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn -
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 333.00 Mn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn -
10 Filana Therapeutics 31.45 Mn -339.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -640,000.00
Sep 30, 2011 -199,000.00
API Access

Filana Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=FLNA&period=max&api_key=YOUR_API_KEY